SARAH ALEXANDER

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease GLENVIEW, IL NPI 1801022124

General Payments — all program years on this page

$3,437.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 217
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $715.23 across 36 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $715.2336

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $80.644
2019 $475.1437
2020 $209.0115
2021 $1,057.2168
2022 $585.5536
2023 $315.1521
2024 $715.2336

Records — PY2024 (36)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086626949 Novartis Pharmaceuticals Corporation $12.88 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626951 Novartis Pharmaceuticals Corporation $12.61 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626953 Novartis Pharmaceuticals Corporation $10.62 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626955 Novartis Pharmaceuticals Corporation $15.27 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626957 Novartis Pharmaceuticals Corporation $16.93 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626959 Novartis Pharmaceuticals Corporation $12.99 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626961 Novartis Pharmaceuticals Corporation $16.93 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626963 Novartis Pharmaceuticals Corporation $19.25 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626965 Novartis Pharmaceuticals Corporation $22.71 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626967 Novartis Pharmaceuticals Corporation $10.62 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626969 Novartis Pharmaceuticals Corporation $12.69 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626971 Novartis Pharmaceuticals Corporation $1.26 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626993 Novartis Pharmaceuticals Corporation $29.92 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626995 Novartis Pharmaceuticals Corporation $15.67 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086626999 Novartis Pharmaceuticals Corporation $5.47 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086627001 Novartis Pharmaceuticals Corporation $24.73 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086627005 Novartis Pharmaceuticals Corporation $12.16 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086627007 Novartis Pharmaceuticals Corporation $14.93 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086627009 Novartis Pharmaceuticals Corporation $31.03 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086627011 Novartis Pharmaceuticals Corporation $12.99 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096817192 Novo Nordisk Inc $23.91 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096846537 Novo Nordisk Inc $25.21 10/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097163158 Novo Nordisk Inc $21.74 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097575579 Novo Nordisk Inc $20.82 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097781031 Novo Nordisk Inc $19.11 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101535465 E.R. Squibb & Sons, L.L.C. $17.21 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105449570 AstraZeneca Pharmaceuticals LP $16.60 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115415767 Amgen Inc. $19.12 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118158547 Boehringer Ingelheim Pharmaceuticals, Inc. $31.07 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118158549 Boehringer Ingelheim Pharmaceuticals, Inc. $34.60 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131126921 PFIZER INC. $31.36 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131254413 PFIZER INC. $25.32 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131999273 PFIZER INC. $32.26 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139880381 SANOFI-AVENTIS U.S. LLC $32.88 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154862350 Kiniksa Pharmaceuticals International, plc $30.87 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154862388 Kiniksa Pharmaceuticals International, plc $21.49 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.